Cable Hill Partners’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Cable Hill Partners’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-286	Closed	-$7K	–	96
2020 Q1	$7K	Hold	286	–	–	﹤0.01%	91
2019 Q4	$14K	Buy	286 +86	+43%	+$4.17K	﹤0.01%	105
2019 Q3	$10K	Buy	200 +57	+40%	+$4.09K	﹤0.01%	107
2019 Q2	$13K	Sell	143 -114	-44%	-$13.9K	﹤0.01%	115
2019 Q1	$38K	Hold	257	–	–	0.01%	287
2018 Q4	$41K	Buy	257 +114	+80%	+$21.9K	0.02%	262
2018 Q3	$31K	Buy	143 +86	+151%	+$20.4K	0.01%	250
2018 Q2	$13K	Hold	57	–	–	0.01%	424
2018 Q1	$14K	Sell	57 -43	-43%	-$11.3K	0.01%	415
2017 Q4	$34K	Buy	100 +71	+245%	+$23.4K	0.01%	293
2017 Q3	$10K	Buy	+29	New	+$10.3K	﹤0.01%	592

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Cable Hill Partners's DMK Position: Q2 2020 in Review

Cable Hill Partners sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2020, closing a stake of 286 shares — an estimated $7K sold.

Cable Hill Partners first reported a position in DMK in Q3 2017 and held it in 11 quarters. The position peaked at $41K in Q4 2018. 47 funds tracked by Wall St. Rank hold DMK as of Q2 2020.

Cable Hill Partners reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2020 after selling out during the quarter.
Cable Hill Partners sold 286 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2020, an estimated $7K.
Cable Hill Partners first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2017 and held it in 11 quarters.
Cable Hill Partners's DMK Pharmaceuticals Corporation Common Stock position peaked at $41K in Q4 2018.
47 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2020.

Based on Cable Hill Partners's 13F filing for Q2 2020, filed 13 Aug 2020.